Mr. Lars Fruergaard Jørgensen has been the Chief Executive Officer and President of Novo Nordisk since January 1, 2017. His company is the largest producer of injectable insulin in the entire world and holds the largest market share in insulin supply, making it one of the most formidable companies on the planet.
Fruergaard is known for his modest ways and effective management. After he was appointed as the CEO of the company, his predecessor was quoted by the Financial Times saying ‘there is no one else who fits the bill more perfectly than Lars’.
In an industry known for aggressive mergers and acquisitions and unrepentant “price gouging”, the world’s largest insulin producer is hoping Mr Fruergaard’s understated approach will make him a good fit to steer the company through a difficult period after his much-adored predecessor resigned from the company.